Vivir Seguros Compania de Seguros de Vida (LIM:VIVSEGC1) Research & Development: S/.0.0 Mil (TTM As of Dec. 2025)


What is Vivir Seguros Compania de Seguros de Vida Research & Development?

Vivir Seguros Compania de Seguros de Vida LIM:VIVSEGC1 Research & Development is S/.0.0 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Vivir Seguros Compania de Seguros de Vida's Research & Development for the six months ended in Dec. 2025 was S/.0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was S/.0.0 Mil.

Vivir Seguros Compania de Seguros de Vida  (LIM:VIVSEGC1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Vivir Seguros Compania de Seguros de Vida Research & Development Related Terms

Vivir Seguros Compania de Seguros de Vida Research & Development Historical Data

* Premium members only.

The historical data trend for Vivir Seguros Compania de Seguros de Vida's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivir Seguros Compania de Seguros de Vida Research & Development Chart

Vivir Seguros Compania de Seguros de Vida Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vivir Seguros Compania de Seguros de Vida Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vivir Seguros Compania de Seguros de Vida Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was S/.0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of S/.0.0 Mil mean?
Vivir Seguros Compania de Seguros de Vida (LIM:VIVSEGC1) has a Research & Development of S/.0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Vivir Seguros Compania de Seguros de Vida and its competitors.
Is Vivir Seguros Compania de Seguros de Vida's Research & Development too high?
Vivir Seguros Compania de Seguros de Vida's current Research & Development is S/.0.0 Mil.
How does Vivir Seguros Compania de Seguros de Vida's Research & Development compare to ?
Vivir Seguros Compania de Seguros de Vida's Research & Development of S/.0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Vivir Seguros Compania de Seguros de Vida and its competitors. Vivir Seguros Compania de Seguros de Vida's current Research & Development is S/.0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivir Seguros Compania de Seguros de Vida stock overvalued right now?
Vivir Seguros Compania de Seguros de Vida (LIM:VIVSEGC1) has a current Research & Development of S/.0.0 Mil. The current Research & Development is S/.0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Vivir Seguros Compania de Seguros de Vida (LIM:VIVSEGC1), the current Research & Development is S/.0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vivir Seguros Compania de Seguros de Vida Business Description

Comparable Companies
Address Avenue Apoquindo 6750, 10th Floor - Las Condes, Santiago, PER
Vivir Seguros Compania de Seguros de Vida SA is a life insurance company. The company is engaged in offering life insurance products including personal accidents, dental insurance, health insurance and life.